Osborne Clarke advises investors on Tagworks Pharmaceuticals $65 Million Series A Financing
Osborne Clarke has advised the syndicate of investors led by Gilde Healthcare and Ysios Capital and with participation from Novartis...
Published on
27/06/2023
Read time
1m